Literature DB >> 11298211

A need to try everything: patient participation in phase I trials.

S Moore1.   

Abstract

RATIONALE: The area of phase I trials is fraught with ethical dilemmas and controversy. Most existing research focuses on issues of human rights and the informed consent procedure. Little attention has been given to patients' perceptions of participating in such trials.
DESIGN: This paper describes a study using qualitative interviews and open-stem questionnaires to begin to explore patients' own perceptions of any benefits from participating in phase I trials.
RESULTS: Findings suggest that for some patients, phase I trials fulfil a need to try everything in their fight against cancer. The study also suggests that being on treatment allows some patients to construct their lives meaningfully by providing a supportive structure and enabling hope. Implications for nursing practice and further research are discussed.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  2001        PMID: 11298211     DOI: 10.1046/j.1365-2648.2001.01715.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  21 in total

1.  American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Authors:  Jeffrey S Weber; Laura A Levit; Peter C Adamson; Suanna Bruinooge; Howard A Burris; Michael A Carducci; Adam P Dicker; Mithat Gönen; Stephen M Keefe; Michael A Postow; Michael A Thompson; David M Waterhouse; Susan L Weiner; Lynn M Schuchter
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

2.  Motivators for participation in a whole-genome sequencing study: implications for translational genomics research.

Authors:  Flavia M Facio; Stephanie Brooks; Johanna Loewenstein; Susannah Green; Leslie G Biesecker; Barbara B Biesecker
Journal:  Eur J Hum Genet       Date:  2011-07-06       Impact factor: 4.246

3.  Understanding Treatment Burden and Quality of Life Impact of Participating in an Early-Phase Pediatric Oncology Clinical Trial: A Pilot Study.

Authors:  Stacey Crane; Lori Backus; Beth Stockman; Janet S Carpenter; Li Lin; Joan Haase
Journal:  J Pediatr Oncol Nurs       Date:  2017-08-29       Impact factor: 1.636

Review 4.  Recommendations for enhancing clinical trials education: a review of the literature.

Authors:  Karen A Stepan; Amy P Gonzalez; Vivian S Dorsey; Debra K Frye; Nita D Pyle; Regina F Smith; Terry A Throckmorton; Louise A Villejo; Scott B Cantor
Journal:  J Cancer Educ       Date:  2011-03       Impact factor: 2.037

5.  Electronic health records as a tool for recruitment of participants' clinical effectiveness research: lessons learned from tobacco cessation.

Authors:  David Fraser; Bruce A Christiansen; Robert Adsit; Timothy B Baker; Michael C Fiore
Journal:  Transl Behav Med       Date:  2013-09       Impact factor: 3.046

6.  Adolescent perspectives on phase I cancer research.

Authors:  Victoria A Miller; Justin N Baker; Angela C Leek; Sabahat Hizlan; Susan R Rheingold; Amy D Yamokoski; Dennis Drotar; Eric Kodish
Journal:  Pediatr Blood Cancer       Date:  2012-10-03       Impact factor: 3.167

7.  Participating in the United Kingdom Prospective Diabetes Study (UKPDS): a qualitative study of patients' experiences.

Authors:  Julia Lawton; Anna Fox; Charles Fox; Ann Louise Kinmonth
Journal:  Br J Gen Pract       Date:  2003-05       Impact factor: 5.386

8.  A qualitative assessment of the experience of participating in a cancer-related clinical trial.

Authors:  Addie C Wootten; Jo M Abbott; Heather M Siddons; Mark A Rosenthal; Anthony J Costello
Journal:  Support Care Cancer       Date:  2009-12-04       Impact factor: 3.603

9.  Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?

Authors:  Nancy Kass; Holly Taylor; Linda Fogarty; Jeremy Sugarman; Steven N Goodman; Annallys Goodwin-Landher; Michael Carducci; Herbert Hurwitz
Journal:  J Empir Res Hum Res Ethics       Date:  2008-09       Impact factor: 1.742

10.  Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation.

Authors:  Tove Godskesen; Peter Nygren; Karin Nordin; Mats Hansson; Ulrik Kihlbom
Journal:  Support Care Cancer       Date:  2013-07-18       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.